ÂÜÀòÂÒÂ×

Nicolas Fellmann currently serves as Chief Financial Officer at Quandela since November 2024. Prior to this role, Nicolas held the position of Chief Financial Officer at Biophytis from May 2023 to October 2024, and at Onxeo from July 2014 to April 2023, where responsibilities included strategy and operations across multiple domains such as finance and investor relations. Nicolas also served as Chief Financial Officer at BioAlliance Pharma from November 2006 to June 2014, and was involved in managing finance and corporate affairs. Earlier in the career, Nicolas worked at Pfizer as Director of Treasury Tax and Audit, managing financial risks and contributing to mergers and change management projects, and started as a Senior Financial Auditor at Ernst & Young. The career began as Deputy CFO at Total. Nicolas holds a Master of Business Administration in Finance from emlyon business school, completed in 1990.